计算核肿瘤学迈向精准放射性药物治疗:现有工具、技术与未知领域
放射性药物治疗(RPT)通过靶向递送细胞毒性电离辐射,对多种恶性肿瘤有显著治疗潜力,对转移性疾病有独特优势。SNMMI人工智能剂量学工作组提出「计算核肿瘤学」范式,用数学模型与计算工具描述RPT剂量反应的病因机制层级,包括影像内照射剂量学的放射药物动力学与映射剂量反应至临床终点的放射生物学。
要点
- RPT可靶向递送细胞毒性电离辐射,对转移性疾病有独特优势。
- SNMMI人工智能剂量学工作组倡导计算核肿瘤学范式。
- 该范式涵盖放射药物动力学与放射生物学两大部分。
核心结论
- SNMMI人工智能剂量学工作组正在推动计算核肿瘤学范式,即用数学模型和计算工具描述RPT剂量反应涉及的病因机制层级。
- 该框架长期有望促进核医学与更广泛的数学和计算肿瘤学界之间的思想交流。
研究设计与样本
- 原文为SNMMI人工智能剂量学工作组提出的观点性论述,未报告系统检索范围或样本量。
主要发现
- RPT通过靶向递送细胞毒性电离辐射,对多种恶性肿瘤有显著治疗潜力,对转移性疾病有独特优势。
- 超越一刀切方法、采用患者特异性影像剂量学进行个体化治疗计划,有机会优化RPT并提高诊疗一体化精度。
- 该方法需要准确的数学模型与工具来预测剂量和临床结局。
- 计算核肿瘤学包括影像内照射剂量学的放射药物动力学和映射剂量反应至临床终点的放射生物学,前者源于药物治疗学,后者源于放射治疗学。
- 上述前身学科开发的模型和方法可作为基础,用于开发更适合RPT的改造工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Radiopharmaceutical therapy (RPT), with its targeted delivery of cytotoxic ionizing radiation, demonstrates significant potential for treating a wide spectrum of malignancies, with particularly unique benefits for metastatic disease. There is an opportunity to optimize RPTs and enhance the precision of theranostics by moving beyond a one-size-fits-all approach and using patient-specific image-based dosimetry for personalized treatment planning. Such an approach, however, requires accurate methods and tools for the mathematic modeling and prediction of dose and clinical outcome. To this end, the SNMMI AI-Dosimetry Working Group is promoting the paradigm of computational nuclear oncology: mathematic models and computational tools describing the hierarchy of etiologic mechanisms involved in RPT dose response. This includes radiopharmacokinetics for image-based internal dosimetry and radiobiology for the mapping of dose response to clinical endpoints. The former area originates in pharmacotherapy, whereas the latter originates in radiotherapy. Accordingly, models and methods developed in these predecessor disciplines serve as a foundation on which to develop a repurposed set of tools more appropriate to RPT. Over the long term, this computational nuclear oncology framework also promises to facilitate widespread cross-fertilization of ideas between nuclear medicine and the greater mathematic and computational oncology communities.
引用
- Yusufaly T, Roncali E, Brosch-Lenz J, et al. Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories. J Nucl Med. 2025. PMID: 39947910. doi:10.2967/jnumed.124.267927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。